Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,011 | 12 | 99.3% |
| Education | $7.29 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $409.86 | 4 | $0 (2020) |
| AbbVie Inc. | $270.81 | 6 | $0 (2021) |
| PFIZER INC. | $240.43 | 2 | $0 (2019) |
| Allergan Inc. | $97.33 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $70.09 | 2 | AbbVie Inc. ($70.09) |
| 2020 | $242.59 | 5 | AbbVie Inc. ($200.72) |
| 2019 | $455.77 | 4 | Regeneron Healthcare Solutions, Inc. ($242.99) |
| 2018 | $249.98 | 2 | Regeneron Healthcare Solutions, Inc. ($125.00) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/11/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: IMMUNOLOGY | ||||||
| 01/21/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $45.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/25/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $48.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: IMMUNOLOGY | ||||||
| 02/19/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.69 | General |
| Category: IMMUNOLOGY | ||||||
| 02/19/2020 | AbbVie Inc. | SKYRIZI (Biological) | Education | In-kind items and services | $7.29 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/30/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $115.45 | General |
| Category: DERMATOLOGY | ||||||
| 03/02/2019 | Allergan Inc. | BOTOX COSMETIC | Food and Beverage | In-kind items and services | $97.33 | General |
| 02/15/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $117.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/12/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 126 | 186 | $76,604 | $12,474 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 43 | $24,811 | $4,570 | 18.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $15,606 | $2,627 | 16.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 16 | 17 | $10,880 | $1,777 | 16.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $6,900 | $1,155 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $5,109 | $1,024 | 20.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 18 | 23 | $10,718 | $926.79 | 8.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 16 | 60 | $2,580 | $395.39 | 15.3% |
About Dr. Joanna Tu, M.D
Dr. Joanna Tu, M.D is a Pediatric Dermatology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2017. The National Provider Identifier (NPI) number assigned to this provider is 1508392887.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joanna Tu, M.D has received a total of $1,018 in payments from pharmaceutical and medical device companies, with $70.09 received in 2021. These payments were reported across 13 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($1,011).
As a Medicare-enrolled provider, Tu has provided services to 126 Medicare beneficiaries, totaling 186 services with total Medicare billing of $12,474. Data is available for 1 year (2023–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Pediatric Dermatology
- Other Specialties Dermatology
- Location San Francisco, CA
- Active Since 05/05/2017
- Last Updated 05/19/2023
- Taxonomy Code 207NP0225X
- Entity Type Individual
- NPI Number 1508392887
Products in Payments
- DUPIXENT (Biological) $284.86
- EUCRISA (Drug) $240.43
- SKYRIZI (Biological) $224.97
- DUPIXENT DUPILUMAB INJECTION (Biological) $125.00
- HUMIRA (Biological) $45.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.